Financials data is unavailable for this security.
View more
Year on year Hansoh Pharmaceutical Group Company Ltd grew revenues 7.69% from 9.38bn to 10.10bn while net income improved 26.85% from 2.58bn to 3.28bn.
Gross margin | 91.01% |
---|---|
Net profit margin | 38.97% |
Operating margin | 45.06% |
Return on assets | 14.82% |
---|---|
Return on equity | 18.10% |
Return on investment | 17.87% |
More ▼
Cash flow in CNYView more
In 2023, Hansoh Pharmaceutical Group Company Ltd increased its cash reserves by 124.31%, or 3.31bn. The company earned 3.12bn from its operations for a Cash Flow Margin of 30.84%. In addition the company generated 1.07bn cash from investing, though they paid out 753.70m more in financing than they received.
Cash flow per share | 0.9121 |
---|---|
Price/Cash flow per share | 19.74 |
Book value per share | 5.05 |
---|---|
Tangible book value per share | 5.02 |
More ▼
Balance sheet in CNYView more
Current ratio | 7.98 |
---|---|
Quick ratio | 7.81 |
Total debt/total equity | 0.0043 |
---|---|
Total debt/total capital | 0.0043 |
More ▼
Growth rates in CNY
SmartText is unavailable
Div yield(5 year avg) | -- |
---|---|
Div growth rate (5 year) | -- |
Payout ratio (TTM) | 24.45% |
EPS growth(5 years) | 8.11 |
---|---|
EPS (TTM) vs TTM 1 year ago | 81.07 |
More ▼